AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Testing for Increased Lipoproteins (a) [LP(a)] in Lymphedema Patients: Li-LY

RecruitingNAAges 18 Years - 99 YearsAllCentre Hospitalier Universitaire de Nice
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Lymphedema is a chronic disease that causes lymph to accumulate in the interstitial tissue. The lymphatic network is involved in the metabolism of lipids and lipoproteins, and this accumulation leads to lipid deposits in the tissues involved. The level of lipoprotein(a) \[LP(a)\] has been shown to be a cardiovascular risk factor, which is partly genetically determined and influenced by certain factors (chronic renal failure, statin treatment, sporting activity or a diet low in saturated fatty acids...). Plasma levels of LP(a) lipoproteins (a) are linearly associated with an increased risk of myocardial infarction and carotid and femoral vascular stenosis. We currently manage patients with primary or secondary lymphedema, whatever the etiology, in the vascular medicine and explorations unit at Nice University Hospital. Those taking part in intensive inpatient decongestive therapy benefit

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Patients over 18 years of age. * Patient with primary or secondary lymphedema confirmed at consultation or in day hospital. * Signature of informed consent. * Person affiliated to or benefiting from a social security scheme Exclusion Criteria: * Person refusing informed consent. * Pregnant or breast-feeding women (urine pregnancy test performed in women of -childbearing age). * Patients undergoing secondary cardiovascular prevention (MI, stroke, AOMI, etc.). * Persons deprived of their liberty by judicial or administrative decision, persons under legal protection.
๐Ÿ’Š

What it tests

  • lipoprotein (a)
๐Ÿ“

Where

2 sites
Chu de Nice
Nice, France
Centre antoine lacassagne
Nice, France
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy